GLP-1 therapy belongs to a class of medications called glucagon-like peptide-1 (GLP-1) agonists
At steady state, the amount of drug being administered each week equals the amount being eliminated, creating a stable concentration
Continue without changes when Symptoms are mild
Patients should be educated about serious adverse effects requiring immediate medical attention, including: Pancreatitis: severe abdominal pain radiating to the back, persistent vomiting Hypersensitivity reactions: rash, difficulty breathing, facial swelling Gallbladder disease: right upper quadrant pain, fever, jaundice Thyroid C-cell tumors (boxed warning): neck mass, dysphagia, hoarseness, persistent dyspnea Regular follow-up with healthcare providers ensures appropriate monitoring and timely intervention if adverse effects occur
Wegovy augments our already existing GLP-1 that leads to decreased hunger, increased fullness and delayed stomach emptying of food, she explains
Starting from scratch